PropThink: AMRN NCE Decision Remains Key; TEVA Potentially In The Race To Buy Is Surprising But Secondary

[ACN Newswire] – By David MoskowitzThursday morning, Israeli financial newspaper Calcalist is reporting that Teva Pharmaceuticals (NASDAQ:TEVA) and AstraZeneca (NYSE:AZN) are leading candidates among other large drug companies … more

View todays social media effects on AZN

View the latest stocks trending across Twitter. Click to view dashboard